DK0615446T3 - Retard-lægemiddel indeholdende et dihydropyridinderivat i nanosolform og fremstilling heraf - Google Patents

Retard-lægemiddel indeholdende et dihydropyridinderivat i nanosolform og fremstilling heraf

Info

Publication number
DK0615446T3
DK0615446T3 DK92924551.2T DK92924551T DK0615446T3 DK 0615446 T3 DK0615446 T3 DK 0615446T3 DK 92924551 T DK92924551 T DK 92924551T DK 0615446 T3 DK0615446 T3 DK 0615446T3
Authority
DK
Denmark
Prior art keywords
nanosol
preparation
drug containing
dihydropyridine derivative
retard drug
Prior art date
Application number
DK92924551.2T
Other languages
English (en)
Inventor
Jens-Christian Wunderlich
Ursula Schick
Juergen Freidenreich
Juergen Werry
Original Assignee
Alfatec Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfatec Pharma Gmbh filed Critical Alfatec Pharma Gmbh
Application granted granted Critical
Publication of DK0615446T3 publication Critical patent/DK0615446T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C1/00—Photosensitive materials
    • G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
    • G03C1/04—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with macromolecular additives; with layer-forming substances
    • G03C1/047—Proteins, e.g. gelatine derivatives; Hydrolysis or extraction products of proteins
    • G03C2001/0471—Isoelectric point of gelatine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK92924551.2T 1991-12-05 1992-12-04 Retard-lægemiddel indeholdende et dihydropyridinderivat i nanosolform og fremstilling heraf DK0615446T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4140194A DE4140194C2 (de) 1991-12-05 1991-12-05 Ein Dihydropyridinderivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung

Publications (1)

Publication Number Publication Date
DK0615446T3 true DK0615446T3 (da) 1996-02-26

Family

ID=6446394

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92924551.2T DK0615446T3 (da) 1991-12-05 1992-12-04 Retard-lægemiddel indeholdende et dihydropyridinderivat i nanosolform og fremstilling heraf

Country Status (8)

Country Link
EP (1) EP0615446B1 (da)
AT (1) ATE130190T1 (da)
AU (1) AU3080692A (da)
DE (2) DE4140194C2 (da)
DK (1) DK0615446T3 (da)
ES (1) ES2082524T3 (da)
GR (1) GR3018930T3 (da)
WO (1) WO1993010770A1 (da)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
DE3515335C2 (de) * 1985-04-27 1995-01-26 Bayer Ag Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
NL194638C (nl) * 1986-12-19 2002-10-04 Novartis Ag Hydrosol die vaste deeltjes van een farmaceutisch actieve stof bevat en farmaceutisch preparaat dat deze hydrosol bevat.
CA1324083C (en) * 1987-03-09 1993-11-09 Tetsu Miyoshi Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
EP0349428B1 (fr) * 1988-06-30 1993-01-20 Centre National De La Recherche Scientifique (Cnrs) Procédé de préparation de systèmes colloidaux dispersibles d'une protéine, sous forme de nanoparticules
US5007790A (en) * 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form

Also Published As

Publication number Publication date
ATE130190T1 (de) 1995-12-15
DE4140194C2 (de) 1998-02-19
EP0615446A1 (de) 1994-09-21
DE4140194A1 (de) 1993-06-09
AU3080692A (en) 1993-06-28
EP0615446B1 (de) 1995-11-15
ES2082524T3 (es) 1996-03-16
DE59204376D1 (de) 1995-12-21
WO1993010770A1 (de) 1993-06-10
GR3018930T3 (en) 1996-05-31

Similar Documents

Publication Publication Date Title
MXPA03011538A (es) Composicion medicinal que sustancialmente no causaria dano a la mucosa intestinal.
DE1001772T1 (de) Verbesserte verabreichungstechnik für multiple medikamentengaben
CY1117470T1 (el) Στερεα δοσολογικα σκευασματα με βελτιωμενη ενδοστοματικη προσροφηση
NO971206D0 (no) Forlenget-frigjöringsformulering
SE9301171D0 (sv) Pharmaceutical composition containing lipophilic drugs
NO20053106L (no) Oral, analgesisk doseringsform med forlenget frigivelse.
HUP9802221A2 (hu) Parazitaellenes hatású markfortin- és paraherkvamidszármazékok
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
ATE292453T1 (de) Antivirale arznei
HU229443B1 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
ATE173627T1 (de) Medizinische zusammensetzung
TW221441B (da)
NO995127D0 (no) Stabiliserte tibolonblandinger
EP0341209A3 (en) Physiologically active substances, a process for preparation and pharmaceutical compositions thereof
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
DK0615446T3 (da) Retard-lægemiddel indeholdende et dihydropyridinderivat i nanosolform og fremstilling heraf
ATE296115T1 (de) Ortsspezifische arzneimittel verabreichung
DE69635775D1 (de) Medikament gegen pulmonale herzprobleme
DK0615439T3 (da) Iburprofenholdigt retard-lægemiddel og dets anvendelse
GB9420748D0 (en) 1,5 benzodiazepine derivatives
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
HUP0104941A2 (hu) Több gyógyszerformát tartalmazó bliszter
ATE326974T1 (de) Blockierung der anlagerung von keimen bei vögeln
TH16069A (th) "วิธีการสำหรับการป้องกันหรือการรักษาการติดเชื้อเอชไอวี-1 หรือเอชไอวี-2"